We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+10.49%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$11.9B
AUM Growth
+$2.55B
(+27%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
15.19%
Top 10 Holdings %
Top 10 Hldgs %
28.34%
Holding
1,181
New
44
Increased
774
Reduced
301
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$294M |
| 2 |
Apple
AAPL
|
+$74.6M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$68.1M |
| 4 |
Tesla
TSLA
|
+$64.9M |
| 5 |
Microsoft
MSFT
|
+$51.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$12.3M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$8.37M |
| 3 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$7.53M |
| 4 |
ASML
ASML
|
+$7.05M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$6.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.81% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 11.37% |
| 4 | Energy | 7.72% |
| 5 | Consumer Discretionary | 3.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Li Auto
LI
$13.4B
| $241K | ﹤0.01% |
+11,796
| New | +$224K |
|
1052
XPeng
XPEV
$12.4B
| $240K | ﹤0.01% |
24,187
+12,486
| +107% | +$113K |
|
|
ITCI
1053
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $236K | ﹤0.01% |
4,467
-254
| -5% | -$12.7K |
|
|
SHOE
1054
Shoe Station Group
SHOE
$413M
| $233K | ﹤0.01% |
9,740
-2,745
| -22% | -$65.6K |
|
1055
Amylyx Pharmaceuticals
AMLX
$2.26B
| $233K | ﹤0.01% |
+6,298
| New | +$224K |
|
|
RVNC
1056
DELISTED
Revance Therapeutics, Inc.
RVNC
| $232K | ﹤0.01% |
+12,580
| New | +$288K |
|
1057
ATI
ATI
$25.6B
| $232K | ﹤0.01% |
7,761
-3,346
| -30% | -$97.9K |
|
1058
Wyndham Hotels & Resorts
WH
$5.56B
| $231K | ﹤0.01% |
3,234
-1,040
| -24% | -$73.5K |
|
1059
Park National Corp
PRK
$3.76B
| $230K | ﹤0.01% |
1,637
+3
| +0.2% | +$422 |
|
|
LBAI
1060
DELISTED
Lakeland Bancorp Inc
LBAI
| $228K | ﹤0.01% |
+12,931
| New | +$231K |
|
1061
Churchill Downs
CHDN
$5.88B
| $227K | ﹤0.01% |
2,150
-1,020
| -32% | -$107K |
|
|
FLNA
1062
Filana Therapeutics
FLNA
$48.8M
| $226K | ﹤0.01% |
7,648
+163
| +2% | +$5.86K |
|
|
NEX
1063
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $225K | ﹤0.01% |
24,376
+6,275
| +35% | +$61.4K |
|
1064
S&T Bancorp
STBA
$1.84B
| $222K | ﹤0.01% |
6,492
-1,178
| -15% | -$41.3K |
|
1065
Fox Class B
FOX
$21.8B
| $221K | ﹤0.01% |
+7,751
| New | +$222K |
|
1066
Arbutus Biopharma
ABUS
$857M
| $220K | ﹤0.01% |
94,505
+40,176
| +74% | +$96.1K |
|
1067
Ingles Markets
IMKTA
$1.71B
| $220K | ﹤0.01% |
2,280
-1,544
| -40% | -$145K |
|
1068
Southside Bancshares
SBSI
$967M
| $219K | ﹤0.01% |
+6,083
| New | +$216K |
|
1069
Zumiez
ZUMZ
$332M
| $219K | ﹤0.01% |
10,063
-1,934
| -16% | -$42.9K |
|
|
VIEW
1070
DELISTED
View, Inc. Class A Common Stock
VIEW
| $218K | ﹤0.01% |
+3,770
| New | +$276K |
|
|
MCHB
1071
Mechanics Bancorp
MCHB
$3.72B
| $218K | ﹤0.01% |
7,897
-493
| -6% | -$13.5K |
|
1072
MP Materials
MP
$7.36B
| $217K | ﹤0.01% |
8,947
-1,252
| -12% | -$37.9K |
|
1073
Towne Bank
TOWN
$3.46B
| $217K | ﹤0.01% |
7,027
-1,195
| -15% | -$37K |
|
|
PGTI
1074
DELISTED
PGT, Inc.
PGTI
| $213K | ﹤0.01% |
+11,883
| New | +$242K |
|
1075
Beazer Homes USA
BZH
$877M
| $213K | ﹤0.01% |
16,719
+1,844
| +12% | +$22.4K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Rafferty Asset Management held 1,181 positions worth $11.9B, up 27% from $9.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Rafferty Asset Management deployed $1.81B of net new capital in Q4 2022, opening 44 new positions and adding to 774 existing holdings. Its largest new stake was Akero Therapeutics: 187,799 shares worth $10.3M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Microchip Technology, an estimated $12.3M trimmed.
- Rafferty Asset Management's largest Q4 2022 buy was Akero Therapeutics: 187,799 shares worth $10.3M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q4 2022, an estimated $294M increase.
- Rafferty Asset Management's biggest Q4 2022 reduction was Microchip Technology, cutting an estimated $12.3M.
- Rafferty Asset Management fully exited CONTINENTAL RESOURCES INC. in Q4 2022, selling an estimated $7.53M.
- Rafferty Asset Management's ten largest holdings make up 28% of its $11.9B portfolio in Q4 2022.
- Rafferty Asset Management opened 44 new positions and closed 61 in Q4 2022.
- Rafferty Asset Management's portfolio value rose 27% quarter-over-quarter to $11.9B.
Based on Rafferty Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.